“Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study”, Swiss Med Wkly, vol. 153, no. 6, p. 40090, Jun. 2023, doi: 10.57187/smw.2023.40090.